Results 41 to 50 of about 2,813 (193)

Brain Oligometastasis from Synchronous Uterine Malignancies

open access: yesIndian Journal of Surgical Oncology, 2020
Synchronous tumors of female genital tract have been uncommonly reported in literature. The most likely scenario would represent a metastatic disease from a primary tumor within the genital tract as the presence of primary synchronous tumors of the genital tract is an extremely rare event. Most primary synchronous tumors tend to involve the endometrium
Varadharajan Vijayakumar   +5 more
openaire   +3 more sources

MicroRNA Expression Characterizes Oligometastasis(es)

open access: yesPLoS ONE, 2011
Background: Cancer staging and treatment presumes a division into localized or metastatic disease. We proposed an intermediate state defined by ≤5 cumulative metastasis(es), termed oligometastases. In contrast to widespread polymetastases, oligometastatic patients may benefit from metastasis-directed local treatments.
Yves A Lussier   +19 more
openaire   +5 more sources

Adrenal oligometastasis cured with stereotactic ablative radiotherapy

open access: yesRadiology Case Reports, 2020
Stereotactic ablative radiotherapy (SABR) has emerged as an effective, noninvasive alternative to surgery in patients with oligometastatic disease. Historically, select patients with adrenal oligometastases have been treated with adrenalectomies which can offer durable local control and reasonable survival rates.
Julia Malone, BSC   +3 more
openaire   +3 more sources

Distribution of treatment modalities and the state of metastatic lesions (oligometastasis or multimetastasis).

open access: yes, 2016
Distribution of treatment modalities and the state of metastatic lesions (oligometastasis or multimetastasis).
Chuanben Chen (845333)   +7 more
core   +1 more source

Late metastatic presentation is associated with improved survival and delayed wide‐spread progression after ablative stereotactic body radiotherapy for oligometastasis

open access: yesCancer Medicine, 2021
Background Stereotactic body radiotherapy (SBRT) is increasingly used to treat oligometastatic disease (OMD), but the effect of metastasis timing on patient outcomes remains uncertain.
Xuguang Chen   +11 more
doaj   +1 more source

Oligometastasis to testis in prostate cancer: Role of gallium-68 prostate-specific membrane antigen positron-emission tomography computed tomography

open access: yesWorld Journal of Nuclear Medicine, 2021
Accurate staging and restaging with early detection of recurrent site is the key for planning treatment in patients of prostate cancer. Recently, gallium-68 prostate-specific membrane antigen positron-emission tomography computed tomography (68Ga-PSMA ...
Manoj Gupta   +3 more
doaj   +1 more source

Additional file 1 of Patients with metastatic renal cell carcinoma who receive immune-targeted therapy may derive survival benefit from nephrectomy

open access: yes, 2023
Additional file 1: Table 1. Category and dosage of target medicine and PD-1 inhibitors. Table 2. Two groups of PD-1 inhibitors combined with targeted therapy. Table 3.
Zhe Sun (328682)   +8 more
core   +1 more source

Metastatic survival curves stratified by treatment modalities in different number of metastases: oligometastasis (A) and multimetastasis (B).

open access: yes, 2016
Metastatic survival curves stratified by treatment modalities in different number of metastases: oligometastasis (A) and multimetastasis (B).
Chuanben Chen (845333)   +7 more
core   +1 more source

Complete Surgical Resection of Rare Solitary Anterior Mediastinal Metastasis From Ovarian Clear Cell Carcinoma

open access: yesRespirology Case Reports, Volume 14, Issue 11, November 2026.
Here, we report an extremely rare case of a solitary anterior mediastinal metastasis from ovarian clear cell carcinoma. The lesion was successfully managed with complete R0 surgical resection via median sternotomy. In patients with a history of ovarian clear cell carcinoma, aggressive surgical intervention should be considered for isolated thoracic ...
Teruhisa Chiba   +6 more
wiley   +1 more source

Genomic features and its potential implication in bone oligometastatic NSCLC

open access: yesBMC Pulmonary Medicine, 2023
Objectives Emerging evidence have demonstrated that oligometastatic non-small cell lung cancer (NSCLC) can achieve clinical benefit from local consolidative therapy.
Rongxin Liao   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy